Sara Rosenbaum, J.D., is the Harold and Jane Hirsh Professor and founding Chair of the Department of Health Policy, George Washington University School of Public Health and Health Services, a unique center of learning, scholarship, and public service focusing on all aspects of health policy.
Professor Rosenbaum has devoted her career to issues of health law and policy affecting low income, minority, and medically underserved populations. Between 1993 and 1994, Professor Rosenbaum worked for President Clinton, directing the legislative drafting of the Health Security Act and developing the Vaccines for Children program. Professor Rosenbaum also served on the Presidential Transition Team for President-Elect Obama.
A graduate of Wesleyan University and Boston University School of Law, Professor Rosenbaum has authored a leading health law textbook as well as more than 350 articles and studies focusing on all phases of health law and health care for medically underserved populations. A holder of numerous awards for her scholarship and service, Professor Rosenbaum is the recipient of the Richard and Barbara Hansen National Health Leadership Award (University of Iowa), a Robert Wood Johnson Foundation Investigator Award in Health Policy Research, and the Oscar and Shoshanna Trachtenberg Award for Scholarship, George Washington University’s highest award for scholarship.
Professor Rosenbaum is a member of CDC’s Advisory Committee on Immunization Practice (ACIP) and Director’s Advisory Committee. She also serves as a Commissioner on the Medicaid and CHIP Payment and Access Commission, which advises Congress on federal Medicaid and CHIP policy.
Recent Posts by Sara Rosenbaum
The Trump Administration could take steps---under existing legislative authority---to broaden the longstanding definition of “community benefit” spending to promote fuller community-wide health improvement partnerships between tax-exempt hospitals and the communities they serve.
The Supreme Court's 5-3 majority ruling overturning two restrictions on abortion in Texas represents a full-throated reaffirmation of the balancing test first set forth by the Court 25 years ago in Planned Parenthood of Southeastern United States v. Casey.
On April 25, CMS released a behemoth 1,425-page final rule that will guide the delivery of health care for tens of millions of children and adults. This posts provides an overview of what the rule seeks to accomplish and how it tries to position health care delivery under a regulatory system...
The requirement that nonprofit hospitals earn their tax-exempt status by benefiting their communities is enshrined in U.S. tax policy. In the context of ACA reforms, there is increased interest among hospitals in how they might expand the traditional community benefit concept into a newer and...
On November 2, 2015, CMS issued a long-awaited final regulation implementing Medicaid’s so-called “equal access” requirement. It takes modest steps toward creating a stronger evidence base and review process for evaluating the sufficiency of state Medicaid payments in relation to beneficiary...
The current Planned Parenthood fight, one of the most disturbing battles over women’s health in recent years, has been riddled with inaccuracies. A particularly damaging one is the assertion that the nation’s community health centers could pick up the slack if Planned Parenthood is defunded.
Assuming after King v. Burwell that the nation is one Presidential election away from the final word on whether the ACA is here to stay, it is worth reflecting on some of the near-term concerns that emerge as important follow-on policy issues.
CMS’ long awaited Medicaid managed care proposed rules were released on May 26 and published in the Federal Register on June 1. In both vision and sweep, the new proposal represents a defining moment in the life of Medicaid.
In Armstrong v. Exceptional Child, the United States Supreme Court held that providers (and, by implication, beneficiaries) may not turn to the courts for help in requiring that states live up to the minimum legal terms of the Medicaid statute. Here’s what the Obama administration should do now.
Despite concerns outlined in our previous post on reference pricing, federal oversight agencies essentially have taken a hands-off approach. First, they announced that for large group and self-insured plans, the Affordable Care Act's (ACA) annual maximum limits on out-of-pocket costs do not...